Rank #1: CEO Stevens Says HeartFlow Took No Shortcuts to Commercialization, Raising $240 million Series E
Overview: HeartFlow has built a strong financial argument for its imaging system.
Surprises: This stuff belongs on Star Trek. Very cool.
Takeaway: "There are no shortcuts."
Mar 06 2018
Rank #2: Justin Klein, MD, JD, Partner at New Enterprise Associates
Feb 29 2016
Rank #3: HealthQuest’s Kong on teamwork, Medtech, and investing $225 million
Mar 30 2016
Rank #4: Relievant CEO Kevin Hykes Shares the Advice that Led Him to Set a Successful Course as CEO
Jul 13 2018
Rank #5: Advice of the Valkyrie – GE Venture’s Lisa Suennen Explains How Medtechers Can Find Their Voice
Apr 06 2017
Rank #6: Foundry’s Gifford: Innovating Innovation in a Changing Health Care World
Apr 23 2015
Rank #7: Stryker’s Kevin Lobo Explains Why He Calls Medtech Home, How the “Serial Acquirer” Will Keep Growing
Growing up in Canada, Kevin Lobo only knew he wanted to be a senior executive at a global company someday. That overriding objective took him through the consumer good and chemical industries before the financial executive found his first job in Medtech. In this interview conducted at the Medtech Conference in Minneapolis, Lobo reveals that while he first was reluctant to take that Medtech job, he’s now grateful to have found a home. “If you’ve only been in Medtech, you do not understand how lucky you are to be in this industry.” Lobo shares insights on how he built a career that positioned him to lead one of Medtech’s giant. He also explains why under his watch Stryker grew to become a “serial acquirer” of that has spent $14 billion to acquire 55 companies during his tenure as CEO.
Jun 17 2019
Rank #8: SVB’s Jon Norris Reveals Medtech’s Most Prolific Investors, Hottest Areas, and Biggest Exits
Earlier this month, Silicon Valley Bank released its Trends in Healthcare Investments and Exits 2019, the latest of the bank’s annual reports on the state of healthcare investing. In this podcast we talk with Report Guru (and Managing Director) Jonathan Norris about the top takeaways including:
- What’s the emerging hot spot for Device Start-Ups?
- What VCs are making Series A deals?
- Are Angels and Crowdfunding groups making an impact?
- How busy are Corporates?
- What’s a Big Exit? And why are they on the rise?
Jan 25 2019
Rank #9: Stanford’s Yock Talks Medtech Costs, Biodesign’s Birthday, and How He Feels about Apple and Google
May 03 2017
Rank #10: Managing Director Kirk Nielsen Talks Origins, Medtech, and Versant Ventures’ new $400 Million Fund
Mar 17 2017
Rank #11: Propeller Health CEO David Van Sickle Explains How Sensors, Data Can Help Manage Respiratory Disease
May 11 2018
Rank #12: How Will Abbott & Auris Deals Impact Early Stage Start-ups?
May 03 2016
Rank #13: Ceterix CEO John McCutcheon Is Writing a Different Ending with New Tech That Can Save the Meniscus
Apr 26 2018
Rank #14: How Will CEO Pavlidis Help VytronUS Deliver Disruptive Ultrasound Tool to Treat Afib in the EP Lab?
Nov 03 2017
Rank #15: SVB’s Numbers Guru Jon Norris Points to More Investors, Stronger Exits Facing Medtech in 2018
Hard to find anyone working harder than Jonathan Norris to help us see the forest for the trees.
Jon is a fixture at many conferences including – thankfully – the upcoming Medtech Conference on May 31. But we wanted to get to his insights early. In this Medtech Talk Podcast, Jon and I discuss his report, “Trends in Healthcare Investments and Exits 2018.”
Overview: Jon shares some positive views for Medtech. Good to hear.
Surprises: I didn’t know Jon’s initial career choice.
Regrets: I didn’t get to ask how his pitching arm is doing. Jon still plays ball on a regular basis.
Enjoy the podcast!
Jan 29 2018
Rank #16: FundRx Finding the Formula to Bring LPs, VCs, Individuals to Fund Promising Medtech Start-Ups
Feb 24 2017
Rank #17: Mylea Charvat Says Savonix Working to Turn Cognitive Function into Vital Measure
Oct 20 2017
Rank #18: NxThera CEO Bob Paulson Talks M&A, Career Twists, Family, and Lessons Learned from Selling Yogurt
May 07 2018
Rank #19: Wahr says Nuvaira gives him a familiar feeling; lays out plans for fund-raising, commercial launch
Oct 13 2017
Rank #20: CEO John Pedersen Explains Why Urology – and Augmenix – Are Enjoying Such an “Interesting Time”
Jun 13 2018